APOE and atherosclerosis: The key role of TGF-β in maintaining DCs tolerogenicity was demonstrated by knocking out a TGF-β receptor, TGFBR2, in CD11+ DCs, which led to the formation of pro-inflammatory and pro-atherogenic CD11+CD8+ cells and the accelerated progression of atherosclerosis in apoE-deficient mice [85].